NCT03025945View on ClinicalTrials.gov

Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo

NACompletedINTERVENTIONAL
Enrollment

662

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Cystoid Macular Edema
Interventions
DRUG

Nepafenac 0.3%

DRUG

Saline Solution

Sponsors
All Listed Sponsors
lead

Intuor Technologies, Inc.

INDUSTRY